Newsletter of MEDICA | View in browser | Deutsch | Print

AI voice diagnostics for heart failure

Dear Sir or Madam,

Noah Labs UG is setting new standards in telemedical monitoring through its AI technology. By analyzing the sound of the patient's voice, the Berlin-based start-up enables early detection of heart failure and improved treatment of cardiac deterioration.
Find out in our interview how this development is changing conventional patient care and contributing to sustainable support for the healthcare system.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

	Interview: AI recognizing heart failure through voice analysis
	13th MEDICA Start-up COMPETITION - Submit solutions
	Newsletter Service

Image: Banner with the text: MEDICA Magazine – 365 days a year; Copyright: Messe Düsseldorf

AI recognizing heart failure through voice analysis

Interview – DIGITAL HEALTH

Image: Woman holding a cell phone in her hand in front of her face and speaking into it

In the future, artificial intelligence will monitor patients with advanced heart failure telemedically by the sound of their voice. This will make it possible to detect and treat deterioration at an early stage. The Berlin start-up Noah Labs UG has developed the AI required for this.

Click here for the interview

	AI recognizing heart failure through voice analysis
	Read all content from the Sphere of DIGITAL HEALTH in the MEDICA Magazine here

To top

Join the 13th MEDICA Start-up COMPETITION 2024 now

Image: Graphic for the "13TH MEDICA Start-up COMPETITION"; Copyright: Messe Düsseldorf

The 13th MEDICA Start-up COMPETITION aims to take healthcare startups to the next level by creating valuable connections and worldwide visibility.

Innovators from around the globe are welcome to submit their solutions for free and be among the Top12 Medical Start-ups 2024 at MEDICA, the world’s largest trade-fair in the healthcare industry.

Conditions of Submission:
• Submission categories: AI in healthcare | Robotics | Health apps | Lab
Diagnostics | Others
• Available at least in one market until the end of Q2 2025 and not launched
before 2021

The pitch and award ceremony will be hosted at the MEDICA INNOVATION FORUM on November 12th, 2024, from 3 PM to 5 PM. Participants stand to gain international exposure, access to potential business partners and investors, free marketing services, and cash prizes totalling up to 3,500 euros.

Submit your solution NOW

To top

Harnessing AI for medical imaging of lymphatic cancer cases

News

MED TECH & DEVICES

Researchers at Chalmers University of Technology unveil an AI model capable of detecting lymphatic cancer with 90 percent accuracy, improving medical imaging analysis. This new technology promises to enhance diagnostic capabilities and streamline patient care.

To top

Diabetes: technology enhances molecular understanding

News

LAB & DIAGNOSTICS

With over seven million individuals in Germany affected by diabetes, science still faces challenges in drug research. However, under the leadership of Prof. Peter Loskill from both the NMI and the University of Tübingen, scientists have devised a method that markedly enhances our understanding at the molecular and cellular levels within the pancreas.

To top

Advanced cell sorting with laser and AI

News

LAB & DIAGNOSTICS

The Fraunhofer Institutes for Laser Technology ILT and for Production Technology IPT developed a new AI-assisted high-throughput process that enhances cell isolation. This presents vast implications for personalized medicine, drug development, and clinical research.

To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top

Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.